My research focuses on transforming growth factor β (TGF-β) signaling, which drives a wide range of cellular and pathophysiologic processes in the mammalian system. One of the major long-term goals is to gain fundamental understanding of how TGF-β-dependent pathways control vascular functions during tumor angiogenesis, particularly as they relate to mechanisms governing acquired resistance to existing VEGF and TGF-β targeted therapies. Another major area of study involves mass spectrometry/proteomics-based approach to identify novel roles for the key TGF-β effectors such as SMADs and TAK1. More recently, the lab has discovered dynamic new roles for these proteins in mitochondrial and microtubule functions. Current projects explore how these proteins contribute to mitochondrial and microtubule dysfunction during cancer progression and in neurodegenerative conditions.
Nam Lee, Ph.D.
Professor, Pharmacology
Professor, Chemistry & Biochemistry
Contact Information
Office: 5224A1Building: Arizona Health Sciences
Phone: (520) 626-1972
Email: namlee@arizona.edu
- 2005 - Ph.D. University of Iowa (Biophysical Chemistry)
- 1997 - BA - University of Iowa (Biochemistry)
Research Area:
Research Interests:
Honors and Awards:
2011-2015 - K99/R00NIH Career Development Award, NHLBI
2009 - Duke University Bell Award in Basic Cancer Research
2008-2010 - F32 NIH NRSA Postdoctoral Fellowship, NCI
2006-2007 - Duke Medical Oncology Research Fellow
2002-2004 - Department of Defense Breast Cancer Research Predoctoral Fellowship